Viewing StudyNCT00087022



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00087022
Status: COMPLETED
Last Update Posted: 2018-11-27
First Post: 2004-07-08

Brief Title: Monoclonal Antibody Therapy Rencarex in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
Sponsor: Heidelberg Pharma AG
Organization: Heidelberg Pharma AG

Conditions & Keywords Data

Conditions:
Name
Kidney Cancer
Keywords:
Name View
stage IV renal cell cancer View
clear cell renal cell carcinoma View
stage I renal cell cancer View
stage II renal cell cancer View
stage III renal cell cancer View